SANTIAGO, Chile, March 31, 2026 (GLOBE NEWSWIRE) -- You are cordially invited to participate in Banco Santander Chile's (NYSE: BSAC) conference call-webcast on Wednesday May 6, 2026, at 12.00 PM NY time where we will discuss 1Q 2026 financial results. The Bank's Officers participating in the conference call are: Patricia Pérez, CFO, Cristian Vicuña, Chief Strategy Officer & Head of IR, and Andres Sansone, Chief Economist. A question and answer session will follow the presentation. The Management Commentary ...

0.0 % (0.0) % 0 bps Income Before Income Taxes $ 347 $ 436 (20.4) % Earnings Per Share (diluted) $ 0.09 $ 0.13 (30.8) % Electro-Sensors, Inc. Announces 2025 Year-End Financial Results Accessibility StatementSkip Navigation MINNETONKA, Minn., March 30, 2026 /PRNewswire/ -- Electro-Sensors, Inc. (NASDAQ: ELSE), a leading global provider of machine monitoring sensors and hazard monitoring systems, today announced financial results for the year ended December 31, 2025. Table in thousands, except per share d ...

DEME today released its Annual Report 2025, which provides a comprehensive overview of the group’s strategy, operational performance, ESG progress, and financial results. It is the fourth such report since the company's stock listing in 2022. As announced at the end of February 2026, last year proved to be yet another record year for DEME, with all-time high profitability, building on the strong momentum of previous years. 2026 is also shaping up to be a milestone year as DEME is celebrating its 150th anniv ...

FREEHOLD, NJ, March 23, 2026 (GLOBE NEWSWIRE) -- UMH Properties, Inc. (NYSE: UMH) (TASE: UMH), a real estate investment trust (REIT) specializing in manufactured home communities, announced that it will host its First Quarter 2026 Financial Results Webcast and Conference Call. Senior management will discuss the results, current market conditions and future outlook on Friday, May 1, 2026, at 10:00 a.m. Eastern Time. UMH’s First Quarter 2026 results will be released on Thursday, April 30, 2026, after the clos ...

Financial Performance - The company reported a full year revenue of USD 636 million, reflecting a 3% decline from the previous year due to weakening prices and global uncertainty [3] - Despite the revenue decline, the company managed to increase the volume traded for both ores and alloys by 6%, which was a strategic move to control unit fixed costs [3] Market Conditions - The decline in revenue was attributed to weakened demand and unfavorable market conditions [3] - The company is navigating through a challenging market environment characterized by global uncertainty [3] Strategic Initiatives - A key strategic initiative in 2025 involved ramping up trading volumes to mitigate the impact of fixed costs [3]

Core Viewpoint - BW LPG Limited reported a strong financial performance for Q4 2025, with a profit attributable to equity holders of US$104 million, translating to earnings per share of US$0.69, driven by solid shipping performance and positive results from Product Services [1] Financial Performance - The Q4 2025 profit attributable to equity holders was US$104 million [1] - Earnings per share for Q4 2025 stood at US$0.69 [1] - TCE (Time Charter Equivalent) income for Q4 2025 was US$50,300 per available day, exceeding the guidance of US$47,000 per day and the previous figure of US$48,100 per calendar day [1]

Core Insights - Tallinna Sadam's sales revenue for 2025 was €119 million, a slight decrease of 0.8% compared to the previous year, while adjusted EBITDA increased by 6% to €56.5 million and profit rose by 17.3% to €22.5 million [1][12] - The fourth quarter of 2025 saw a revenue increase of 1.3% to €29.2 million, despite a decrease in adjusted EBITDA and profit [5][9] Financial Performance - Total revenue for 2025 was €118.7 million, down from €119.6 million in 2024, primarily due to a decline in charter fee revenue from the icebreaker Botnica [8] - Adjusted EBITDA for the year increased to €56.5 million, with a margin improvement from 44.4% to 47.6%, although it decreased by 8.5% in Q4 [10] - Profit for the year was €22.5 million, up from €19.2 million in 2024, while Q4 profit decreased to €3.6 million [12] Operational Highlights - Passenger numbers increased by 0.9% in Q4 and 1.0% for the full year, while cargo volumes rose by 6% in Q4 and 5% for the year [2] - The number of vessel calls decreased by 4.8% in Q4, but vessel dues revenue increased by 10.3% due to larger vessels visiting the ports [9] Investments - Total investments in 2025 amounted to €33.2 million, a decrease of 14% from the previous year, with significant investments in infrastructure and the completion of the multifunctional quay in Paldiski South Harbour [13][14] - Q4 investments were notably higher at €12.4 million, primarily for the construction of the Paldiski quay [14] Key Events - The cruise season was extended into winter, and the construction of the multifunctional quay in South Paldiski Harbour was completed [6] - EU support was received for the construction of onshore power supply for cruise ships [6]

Core Viewpoint - Option Care Health, Inc. reported strong financial results for the fourth quarter and full year of 2025, highlighting its commitment to patient care and sustainable growth in a dynamic industry environment [2][5]. Financial Highlights Fourth Quarter 2025 - Net revenue reached $1,465.4 million, an increase of 8.8% year-over-year - Net income was $58.5 million, a decrease of 2.7% - GAAP diluted earnings per share (EPS) was $0.37, up 5.7% - Adjusted EBITDA was $126.0 million, up 3.7% - Adjusted diluted EPS was $0.46, up 4.5% - The company repurchased $95 million of stock during the quarter [5]. Full Year 2025 - Total net revenue was $5,649.5 million, up 13.0% from the previous year - Net income totaled $207.6 million, down 2.0% - GAAP diluted EPS was $1.27, up 3.3% - Adjusted EBITDA reached $471.3 million, an increase of 6.2% - Adjusted diluted EPS was $1.72, up 8.9% - Cash provided by operating activities was $258.4 million - The company repurchased $307 million of stock throughout the year [5]. Financial Guidance for 2026 - Option Care Health anticipates net revenue between $5.8 billion and $6.0 billion - Expected adjusted diluted EPS is projected to be between $1.82 and $1.92 - Adjusted EBITDA is forecasted to be between $480 million and $505 million - Cash provided by operating activities is expected to be at least $340 million [6]. Company Overview - Option Care Health is the largest independent provider of home and alternate site infusion services in the U.S., employing over 8,000 team members, including more than 5,000 clinicians [4]. - The company aims to elevate care standards for patients with acute and chronic conditions across all 50 states [4].

Core Viewpoint - RingCentral, Inc. (RNG) shares have surged approximately 30 percent following the announcement of its fourth-quarter financial results, indicating a positive market reaction to the company's profitability turnaround [1][2]. Financial Performance - The company reported a profit of $22.97 million, or $0.26 per share, for the fourth quarter, a significant improvement from a net loss of $7.19 million, or $0.08 per share, in the same period last year [1]. - Total revenue for the fourth quarter of 2025 was $644.0 million, up from $615.5 million in the fourth quarter of 2024, reflecting a year-over-year growth of 5 percent [2]. Stock Performance - The stock is currently trading at $38.25, which is an increase of 30.95 percent or $8.94 from the previous close of $29.35 on the New York Stock Exchange [2]. - Over the past year, the stock has traded within a range of $20.59 to $38.25 [2].

Core Insights - Labcorp reported strong financial performance for Q4 2025 and the full year, with revenue growth of over 7% and double-digit adjusted EPS growth, driven by its Diagnostics and Central Laboratory businesses [1][2] - The company provided guidance for 2026, projecting revenue between $14.61 billion and $14.79 billion, adjusted EPS between $17.55 and $18.25, and free cash flow of $1.24 billion to $1.36 billion [1][2] Financial Performance - Q4 2025 revenue was $3.52 billion, a 5.6% increase from Q4 2024's $3.33 billion; full-year revenue reached $13.95 billion, up 7.2% from $13.01 billion [1][2] - Adjusted EPS for Q4 was $4.07, compared to $3.45 in Q4 2024; full-year adjusted EPS was $16.44, up from $14.57 [1][2] - Free cash flow for Q4 was $490.3 million, down from $665.1 million in Q4 2024; full-year free cash flow increased to $1.21 billion from $1.10 billion [1][2] Strategic Developments - Labcorp completed several acquisitions, including assets from Empire City Laboratories, Incyte Diagnostics, and Community Health Systems, enhancing its service offerings [1][2] - The company announced plans to build a new 500,000 square foot Central Laboratory facility in Indiana, expected to begin construction in late 2026 [1][2] - Labcorp launched new consumer-initiated tests and expanded access to molecular residual disease testing for various cancers, as well as the first FDA-cleared blood test for Alzheimer's disease [1][2] Capital Allocation - In 2025, Labcorp invested $582 million in acquisitions, paid $240.7 million in dividends, and repurchased $450 million of its stock [1][2] - The company reported a cash and cash equivalents balance of $532.3 million and total debt of $5.58 billion at the end of Q4 2025 [1][2] Segment Performance - The Diagnostics Laboratories segment generated $2.73 billion in revenue for Q4 2025, a 5.5% increase from Q4 2024; adjusted operating income was $419.2 million, with a margin of 15.4% [2][4] - The Biopharma Laboratory Services segment reported $793 million in revenue for Q4 2025, a 3.4% increase, with adjusted operating income of $136.1 million and a margin of 17.2% [2][4]